vimarsana.com

Latest Breaking News On - Carl wittwer - Page 6 : vimarsana.com

Co-Diagnostics, Inc Announces Completion of the Acquisition of all Assets and Intellectual Property Related to At-Home/Point-of-Care Platform

/PRNewswire/ Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of.

United statesKirk ririeDwight eganCarl wittwerConceptions incDiagnostics inc nasdaqIdaho molecular incDiagnostics incCompany scientific advisory boardIdaho molecularAdvanced conceptionsScientific advisoryCo diagnostics

Co-Diagnostics, Inc Announces Completion of the Acquisition of all Assets and Intellectual Property Related to At-Home/Point-of-Care Platform

/PRNewswire/ Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of.

United statesKirk ririeDwight eganCarl wittwerConceptions incDiagnostics inc nasdaqIdaho molecular incDiagnostics incCompany scientific advisory boardIdaho molecularAdvanced conceptionsScientific advisoryCo diagnostics

Co-Diagnostics, Inc Announces Completion of the Acquisition of all Assets and Intellectual Property Related to At-Home/Point-of-Care Platform

SALT LAKE CITY, Dec. 31, 2021 /PRNewswire/ Co-Diagnostics, Inc. , a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests,. | December 31, 2021

United statesKirk ririeDwight eganCarl wittwerConceptions incDiagnostics inc nasdaqIdaho molecular incDiagnostics incCompany scientific advisory boardIdaho molecularAdvanced conceptionsScientific advisoryLooking statementsCo diagnosticsNc stock exchangePress release

Co-Diagnostics Inc to acquire Idaho Molecular Inc and Advanced Conception Inc for its at-home/point-of-care platform

The acquisition will streamline the commercialization of the Eikon platform and the YourTest PCR device as it nears completion and prepares.

United statesKirk ririeDwight eganCarl wittwerConceptions incIdaho molecular incAdvance conceptions inc

Co-Diagnostics, Inc Signs Agreement to Acquire all Assets and Intellectual Property Related to At-Home/Point-of-Care Platform

/PRNewswire/ Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of.

United statesKirk ririeDwight eganCarl wittwerDiagnostics incCompany scientific advisory boardScientific advisoryCo diagnostics

vimarsana © 2020. All Rights Reserved.